Search

… ProQR at TIDES to highlight our Axiomer® technology This month several ProQRians will attend … Conference (TIDES Europe) 2022 to highlight our Axiomer® RNA-editing platform technology. This month several …

… focuses on developing potential medicines using our Axiomer RNA editing platform technology. Strategic … drive the advancement of an early-stage technology, like Axiomer, closer to the clinic. Today we are delighted to … announced in September 2021 , applied ProQR’s proprietary Axiomer® RNA editing platform to target disorders of the …

… immense, says Bart Klein, who was at the forefront of the Axiomer® technology development. ProQR’s Sr. Vice President Innovation makes his point about the promise of Axiomer® technology: “This opens up a whole new way of …

… ProQR will focus exclusively on the development of the Axiomer® RNA editing technology platform across multiple … ProQR will focus exclusively on the development of the Axiomer® RNA editing technology platform across multiple …

… focuses on developing potential medicines using our Axiomer ® RNA editing platform technology. Strategic … drive the advancement of an early-stage technology, like Axiomer , closer to the clinic. In any global licensing and … of high unmet need Lenka van Sint Fiet, Director Axiomer Axiomer technology ProQR’s Axiomer ® platform …

… RNA editing technology – accelerate development of the Axiomer ® RNA base-editing technology platform, including …